GE-MSCs/dTRAIL

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGE-MSCs/dTRAIL
Drug Alias Namegenetically engineered mesenchymal stem cells producing direct tumor cell apoptosis (POCASTEM)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionApoptosis modulatorsStem cells modulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPocastem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPocastem
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A